Mo’ money, fewer problems: The Tipline for 4 May 2017
Today we dive into the proposed federal spending bill to see how it might affect antitrust enforcement in the US. We also have coverage of six pharmaceutical companies’ ongoing battle against 40 states regarding two generic drugs, and a deeper look into Tim Muris’ jump to Sidley Austin.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10